J1812 Insulin (fiasp), per 5 units

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj. insulin (fiasp)

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Insulin (fiasp), per 5 units	yes

J1800 Injection, propranolol hcl, up to 1 mg
J1805 Injection, esmolol hydrochloride, 10 mg
J1806 Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
J1807 Injection, ethacrynate sodium, 1 mg
J1808 Injection, folic acid, 0.1 mg
J1809 Injection, fosdenopterin, 0.1 mg
J1811 Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1813 Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814 Insulin (lyumjev), per 5 units
J1815 Injection, insulin, per 5 units
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units
J1823 Injection, inebilizumab-cdon, 1 mg
J1826 Injection, interferon beta-1a, 30 mcg
J1830 Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1833 Injection, isavuconazonium, 1 mg
J1834 Injection, isoniazid, 1 mg
J1835 Injection, itraconazole, 50 mg
J1836 Injection, metronidazole, 10 mg
J1837 Injection, posaconazole, 1 mg
J1885 Injection, ketorolac tromethamine, per 15 mg